MedPath

Comparison of sodium excreting effect between furosemide and indapamide combination with furosemide and metolazone combination in congestive heart failure patients

Not Applicable
Completed
Conditions
Congestive Heart Failure
Registration Number
SLCTR/2017/041
Lead Sponsor
Rehman Medical Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

New York Hear Association Grade –III

New York Hear Association Grade - IV

Adults from 18years to 90years of both genders will be included

Exclusion Criteria

Chronic Kidney Disease - Ultrasonographic evidence of chronic kidney disease

Chronic Liver Disease - Ultrasonographic evidence of liver fibrosis

Malnutrition- serum albumin concentration of less than 3g/dl

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.